# Riluzole Augmentation Pilot in Depression (RAPID) Trial

> **NCT01703039** · PHASE2 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 21 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Riluzole
- **DRUG:** Sertraline
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01703039
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** PI departure, slow recruitment
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703039, "Riluzole Augmentation Pilot in Depression (RAPID) Trial". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT01703039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*